NCT05355701 2026-03-27
A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
Pfizer
Phase 1 Recruiting
Clinical Trials
5 trialsNCT03016819 2026-02-25
APROMISS
Advenchen Laboratories, LLC
Phase 3 Recruiting
NCT04067336 2025-11-10
First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia
Kura Oncology, Inc.
Phase 1/2 Recruiting
NCT06407518 2025-04-06
POMPPR
Sixth Affiliated Hospital, Sun Yat-sen University
Phase NA Recruiting
NCT03343873 2024-08-01
ACTION
Beijing Tiantan Hospital
Phase NA Recruiting